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Background: Knowledge about the actual central nervous system properties of propranolol or 
ascorbic acid remains poorly understood. Information on the neural mechanism of the 
interactions of these compounds in the central nervous system is still very hazy and presently a 
subject riddled with speculations. This study was designed to investigate the possible effects of 
ascorbic acid on open field locomotor activity and normal sleep in healthy adult rats and 
evaluate how these correlate with those of propranolol. MethodS: Eighty healthy adult Wistar 
rats of both sexes were divided into two groups of 40 animals each group. One group received 
ascorbic acid treatment while the other group received propranolol, both of which were 
prepared into different doses, respectively. Each of the various doses of these compounds was 
administered separately for a period of 21 days in each experimental group, while the control 
animals received 0.3ml normal saline for the same period. The results were subjected to 
statistical analysis, using MicroCal Origin Statistical Software version 8.0, and the Student’s 
T- test to compare the results and P values of  ≤ 0.05) were regarded as statistically significant. 
Results: Behavioral activation with increased locomotor activity and wakefulness were 
observed in doses of ascorbic acid while the animals appeared behaviorally-sedated with clear 
sleep promoting effects in the wistar rats in doses of propranolol. Conclusion: It is possible 
from present results that dopaminergic and cholinergic neural mechanisms account for the 
gross behavioral activation rats. It is clearly suggestive that the modulating influence on sleep 




When the behavioural output in the animal changes in 
magnitude, it is generally believed that the change must 
have resulted from alterations in central nervous system 
activity. Workers have noted that an alteration in 
central nervous system activity is influenced by 
humoral mechanism or by intrinsic activity (Ruch and 
Patton, 1966). In one other observation, it was noted 
that chemical agents modify the levels of neural 
activity in the brain to induce behavioural change. It is 
a known fact that one avenue through which a chemical 
agent may act to modify the behavioural output in the 




Sleep is a behavioural state in the animal, and it 
involves complex interactions with all the neural 
systems that traditionally regulate sleep in the brain. 
One of the ways it is possible to study sleep in an 
animal is by the application of a short acting barbiturate 
to evaluate the Onset Time (sleep latency) and Duration 
(total sleep time) of the induced sleep in the animal.  
On the other hand, it is also possible to employ a 
known substance such as ascorbic acid or propranolol 
(both of which are speculated to have some modulating 
influences on sleep) to study the time course of the 
normal sleep in relation to a known drug-induced sleep 
in the animal.                                                                                              
Apart from the neurotransmitter systems that are 
implicated in the central regulatory mechanism of sleep 
and behaviour, a number of endogenous factors have 
also been linked with sleep regulatory functions in the 
brain. In addition, the preoptic and posterior 
hypothalamic areas are known to be deeply involved in 
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the central regulatory functions of sleep, and some 
homeostatic and circadian factors are now believed to 
interact, not only to determine the timing of sleep, but 
also its quality (Siegel, 2005). For example, the 
inhibitory neurotransmitter GABA and Galanin are 
reported to initiate sleep by inhibiting the wakefulness 
and arousal regions of the brain (Siegel et al., 2001). 
These transmitter systems are known to have their 
origin in the ventrolateral preoptic nucleus of anterior 
hypothalamus, a nucleus believe to initiate and can 
inhibit the awake-promoting regions of the brain 
(Siegel, 2005). Furthermore, it is possible to undertake 
an overall assessment of a state of anxiety in the animal 
by way of a monitoring device which keeps track of the 
open field locomotor activity. Locomotor activities may 
be expressed in many forms including such diverse 
motor activities as swimming, flying, walking, running, 
rearing and hopping etc. (McCrea and Rybak, 2008). 
Ascorbic acid (vitamin C), a water-soluble 
micronutrient have been noted for multiple biological 
functions including a cofactor for the synthesis of a 
number of enzymes in post-translational hydroxylation 
of collagen (Aguirre, 2008), it is involved in 
hematopoiesis and for leukocyte formation and tyrosine 
metabolism (Padh, 1990). Ascorbic acid is also known 
to be highly concentrated in the brain (Sjostrand, 1970; 
Kuo et al., 1979), and exhibits preferential distribution 
in the central nervous system (Subramanian, 1977), but 
is not synthesized anywhere in the brain in man and 
other primates (Vitler et al., 1967). Propranolol, on the 
hand, has been classified as a non-selective beta 
blocker, lipid soluble and exhibits sodium channel 
blocking effects. Propranolol is known to cross the 
blood–brain barrier (Steenen et al., 2015), thus, it is 
possible that it may exert some central nervous system 
properties in addition to its known peripheral activities. 
It was the aim of this study to evaluate some open field 
locomotor activities and possible modulating influences 
on the normal sleep of rat in varying but separate doses 
of ascorbic acid and propranolol in Wistar rats. 
 
 MATERIALS AND METHODS 
Eighty healthy rats of both sexes weighing between 180 
- 200gm were used in this study. The animals were kept 
in cages under normal laboratory conditions and 
ambient temperature. The rats were fed with standard 
normal feeds and clean water throughout the 
experiments. The animals were allowed a period of two 
weeks to acclimatize to the environment of the 
laboratory before the commencement of the 
experiments. 
 
The rats were organized into two groups of 40 animals 
each group. One group received ascorbic acid treatment 
in separate single doses 2,4,8,16,32,64,128 and 256 
mg/kg body weight respectively, while the other group 
of 40 rats received propranolol treatment, of these same 
doses. Each experimental Group of 40 animals was 
further subdivided into 8 groups of 5 rats each. A group 
of 5 animals were treated with one of the eight separate 
doses throughout the period of the experiments. An 
animal was observed separately in a transparent 
perspex cage (40cm x 40cm x 1520cm walls 
(Dubovicky et al., 2004) for locomotor activity for a 
period of one hour each session. In this way the 40 
animals of a group was tested in the various doses of 
ascorbic acid or propranolol, respectively. 
 
Determination of drug doses and administration 
A known quantity of drug was dissolved in a volume of 
normal saline, to obtain the stock solution from where 
the different doses (2,4,8,16,32,64,128 and 256 
mg/kg body weight) were determined according to 
the expression: Vol. (ml) = D x W x 1/C, where D is 
the required dose in mg/kg, W is the weight of the 
animal in kilograms and C, the concentration of the 
stock solution in mg/ml. These various doses were 
determination from the ascorbic acid and propranolol 
stock solutions, respectively. 
 The dose was administered intraperitoneally (i/p), after 
which the animal was observed in a quiet room free 
from disturbances and with ambient temperature of 24 
oC, for behavioral activities, for a period of one hour.  
All experiments were restricted to the same seasonal 
period and between 900 hrs – 1800 hrs each day so as 
to avoid behavioral changes associated with seasonal 
and circadian variations.                                                                                               
Experiment for each dose was repeated 5 times using a 
fresh animal each time. The control group of five 
animals received 0.3 ml physiological saline only, for 
the test of either locomotor activity or normal sleep. 
Locomotor activity was registered when the rat crosses 
any of the line grids on the floor of the cage. The 
number of line crossings was recorded using a tally 
counting method. In the sleep experiments, the rats 
were regarded as asleep when they failed to respond to 
a very low noise level, thus, the Onset time and 
Duration of the normal sleep were recorded using a 
stop clock. 
 
All of the behavioural and sleep data from all the 
experiments were pooled and subjected to statistical 
analyses, employing the Micro Cal Origin Statistical 
analysis Software, Version 8.0, and the Students’ t-test, 
and the results were presented as Mean ± SEM, and p 
values (p ≤ 0.05) regarded as statistically significant. 
 
RESULTS 
Data for the influence of ascorbic acid and propranolol 
on normal sleep locomotor activity are presented.   
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Table 1: Mean values of locomotor activity (line crossing) and Normal sleep patterns in separately administered 
doses of Ascorbic acid and Propranolol (n= 5).  
 
*Significant values (*P ≤0.05, **P ≤0.01, ***P ≤0.001) are Mean±SEM compared to control, (n= 5) 
 
Fig.1: Mean values of locomotor activity (line crossing) in 
separate doses of Ascorbic acid and Propranolol in Wistar 
rats. *Significant values (*P ≤0.05, **P ≤0.01, ***P ≤0.001) 





The computed values of the behavioral data in this 
study indicate that the animals were generally 
behaviorally activated (p ≤ 0.05) at the higher dose 
range of ascorbic acid (16-256mg/kg. Thus, the 
behavioural data in Table1 clearly indicate that ascorbic 
acid probably exhibits excitatory effects of on 
locomotor activity in wistar rats (please see also 
Figure1). On the other hand, values of the statistical 
data in Table1 revealed there were behaviorally 
depressive effects (p ≤ 0.05) in the animals after their 
treatment with doses of propranolol (see Figure 1). 
Thus, this later observation in doses of propranolol 
 Fig. 2: Mean Onset time (min) of Sleep in varying doses of 
ascorbic acid and propranolol, respectively, in Wistar rats. 
*Significant values (*P ≤0.05, **P ≤0.01, ***P ≤0.001) are 
Mean ± SEM, compared to control, (n= 5). NB: Values 
greater than sixty (60) minutes indicate wakefulness. 
 
 
treatment in this study is noted as largely in agreement 
with earlier reports that noted suppressive effects on 
locomotor activity in mice treated with propranolol 
(Eric et al., 1995; Huaying et al., 2011). Furthermore, 
the increase in open field locomotor activity observed 
in doses of ascorbic acid in this study is also noted as 
consistent with earlier reports of gross behavioral 
activation in rats following treatments with ascorbic 
acid (Abbasnejad and Shahsevari 2013), behavioral 
excitatory effects in low doses of administered ascorbic 
acid in Wistar rats (Ezenwanne and Anuka, 1991). The 
observation in the experiments   with ascorbic acid in  
the present study also corresponds well with an earlier 
report which noted sedative influences (depressive 
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effects) in Wistar rats as the result of deficiency of 
ascorbic acid (Lyhs, 1961). 
 
Fig. 3: Mean values of Sleep duration in separate doses of 
Ascorbic acid and Propranolol in Wistar rats. *Significant 
values (*P ≤0.05, **P ≤0.01, ***P ≤0.001) are Mean±SEM 
compared to control (n= 5).  
 
 The observation in open field locomotor activity in this 
study is noted as further proof of possible central 
nervous system excitatory property of ascorbic acid. 
Essentially, this is regarded as a clear demonstration 
which supports the notion or research proposals that 
ascorbic acid probably exhibits some clearly definable 
central nervous system activity of suppressive influence 
on central mechanism of sleep. The sleep study data 
also showed that the animals tended to stay longer time 
in sleep (sleep duration) after  they were treated with  
propranolol, as opposed to the animals showing the 
greater tendency to remain longer in the state of 
wakefulness after treatment with ascorbic acid (please 
see Figure 3). The decreased Onset Time of sleep (p ≤ 
0.05) in doses of propranolol, as compared to the longer 
sleep Onset Time (p ≤ 0.05) in doses of ascorbic acid in 
this study, can be noted as additional evidence which 
demonstrated that ascorbic acid and propranolol may 
exhibit mutually opposing properties in the central 
nervous system (Figure 2).      
             A number of earlier workers reported increases 
in sleeping time in rats and mice after treatments with 
doses of propranolol (Laverty and Taylor 1968), and 
there were also reports of increase in wakening time 
from sleep in humans after treatment with propranolol 
(Taşkın et al., 2015). There was also the proposal that 
sedative effect in the brain is generally linked to the 
GABA neural mechanism. In this study, sleep 
promoting influences of propranolol was clearly 
revealed within all the experimental animals. In the 
light of these reports and in view of the present 
observations, it is possible that the sleep promoting 
effects of propranolol in this study was mediated 
through GABA or Galanin neural mechanism. In a 
sleep model, some workers proposed the presence of a 
factor for sleep which is believed to use the inhibitory 
neurotransmitter GABA and Galanin to initiate sleep by 
inhibiting the arousal regions of the brain (Siegel et al., 
2001; McDonald, 2010). Nevertheless, there are also 
the reports in which workers proposed that sleep 
production processes and behavioural effects of the 
brain are generally mediated through cholinergic neural 
mechanism (Espana and Scammell, 2004). 
Furthermore, in earlier reports also some workers were 
of the opinion that the central mechanism of action of 
ascorbic acid in the brain is generally mediated through 
dopaminergic system (Van Rossam and Hurkmans, 
1964). However, presently research findings or reports 
on the possible central mechanisms of action of 
ascorbic acid are still very scanty. Nevertheless, it is 
possible that the cholinergic neural mechanism can 
account for the gross behavioral activation of ascorbic 
acid reflected in the increase in open field locomotor 
activity, observed in this study.   
In view of the observations in this study, and in the 
light of similar reports by earlier workers, it is possible 
that the cholinergic and dopaminergic neural 
mechanisms. It is hoped that future studies will further 
elucidate the specific neural mechanisms implicated in 
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